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Summary
  Introduction:  The influenza burden among children is underestimated. The aim of our study was to estimate the 
accuracy of the rapid influenza detection test (RIDT) BD Directigen™ EZ Flu A+B® and direct 
immunofluorescence assay (DFA) used among children with influenza-like illness (ILI) consul-
ted in the ambulatory care clinic.
  Material/Methods:  A total of 150 patients were enrolled in the study. Inclusion criteria were: age less than 59 mon-
ths, presentation of ILI according to the CDC (Centers for Disease Control and Prevention) defi-
nition (fever >37.8°C, cough and/or sore throat in the absence of another known cause of illness), 
duration of symptoms shorter than 96 hours. Two nasal swabs and one pharyngeal swab were ob-
tained from patients and tested by RIDT, DFA and real time RT-PCR as the reference method.
  Results:  For influenza A (H1N1)pdm09 virus sensitivity of RIDT was 62.2% (95% CI 46.5–76.2%), 
specificity 97.1% (95% CI 91.8–99.4%), PPV 90.3% (95% CI 74.3–98%), NPV 85.7% (95% 
CI 78.1–91.5%), for DFA sensitivity was 60% (95% CI 51.9–63.2%), specificity 96% (95% CI 
88.7–98.8%), PPV 93.1% (95% CI 80.5–98%), NPV 72.7% (95% CI 67.2–74.9%). Analysis of 
logistic regression revealed that the chance of receiving a true positive result of RIDT was twi-
ce as high when the test was conducted during the first 48 hours of symptoms (OR 0.40 vs OR 
0.22).
  Conclusions:  The accuracy of RIDT is comparable with DFA and both methods are very specific but modera-
tely sensitive in diagnosis of influenza in young children. Both methods may be recommended 
for screening for influenza among children.
  Key words:	 influenza	•	rapid	influenza	diagnostic	test	•	direct	immunofluorescence	assay	•	children
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       -               -               -               -               -       Background
Influenza virus is a highly contagious agent that affects in-
dividuals of all ages and plays an important worldwide role 
by causing epidemics and pandemics. Since the signs and 
symptoms of influenza are similar to other respiratory vi-
ral infections, the differential diagnosis of influenza may 
be difficult, even impossible, when based solely on clini-
cal symptoms. Laboratory diagnosis of influenza is criti-
cal not only for its treatment and surveillance, but also for 
its prevention and control [27,32].
Laboratory testing for influenza has historically been of 
questionable value for the management of patients with 
influenza, because of limited test sensitivity, long turna-
round times, and a lack of effective therapy [21,24]. The 
development of more rapid and accurate tests for the de-
tection of influenza now enables the laboratory to provi-
de a prompt, definitive diagnosis, which allows clinicians 
to initiate modern antiviral therapy within 48 hours from 
the disease onset, limit the injudicious use of antibacterial 
agents, implement appropriate infection control measures, 
decrease the duration of hospital isolation, reduce ancillary 
testing, and decrease health costs [9,10,11,13,17,19,25,26].
Laboratory diagnosis of influenza can be accomplished by 
detection of the virus or the patient’s immune response to 
the virus. Diagnostic approaches for identification of the 
virus include viral isolation, detection of viral antigens by 
immunospecific assays (immunofluorescence microsco-
py), rapid influenza detection test (RIDT – based on opti-
cal immunoassay or immunoenzymatic assay), and detec-
tion of viral nucleic acid by use of amplification testing 
(RT-PCR, real time RT-PCR). Antibody detection is usu-
ally accomplished by virus neutralization (virus NT) and 
hemagglutinin inhibition (HI) tests conducted to moni-
tor seroconversion to a specific virus strain or to determi-
ne the immune status, for example, after vaccination [21].
Streszczenie
  Wprowadzenie:  Grypa stanowi u dzieci istotny, ale niedoceniany i nieoszacowany problem kliniczny i epidemiolo-
giczny. Celem pracy było porównanie wiarygodności szybkiego testu diagnostycznego w kierunku 
grypy BD Directigen EZ Flu A+B® z metodą immunofluorescencji bezpośredniej w odniesieniu do 
metody real time RT-PCR u dzieci zgłaszających się do ambulatorium z objawami grypopodobnymi.
 Materiał/Metody:  Do badania włączono 150 dzieci, kryteriami włączenia do badania były: wiek poniżej 59 miesię-
cy życia, występowanie objawów grypopodobnych, zgodnych z definicją CDC: gorączka ≥37,8°C, 
kaszel, ból i/lub zaczerwienienie gardła, utrzymywanie się objawów ≤96 godzin. U pacjentów 
pobrano wymaz z nosa i z gardła i poddano badaniu z użyciem RIDT i/lub DFA, a wyniki zwe-
ryfikowano metodą real time RT-PCR.
  Wyniki:  Metoda RIDT charakteryzowała się w odniesieniu do wykrywania zakażeń wywołanych wiru-
sem grypy A (H1N1)pdm09: czułością 62,2% (95% CI 46,5–76,2%), swoistością 97,1% (95% 
CI 91,8–99,4%), PPV 90,3% (95% CI 74,3–98%), NPV 85,5% (95% CI 78,1–91,5%), podczas 
gdy metoda DFA charakteryzowała się: czułością 60% (95% CI 51,9–63,2%), swoistością 96% 
(95% CI 88,7–98,8%), PPV 93,1% (95% CI 80,5–98%), NPV 72,7% 995% CI 67,2–74,9%). 
Analiza regresji logistycznej wykazała, że szansa na uzyskanie prawdziwie dodatniego wyniku 
RIDT była dwukrotnie wyższa, gdy badanie wykonywano w ciągu 48 godzin od pojawienia się 
objawów chorobowych (OR 0,40 vs OR 0,22).
  Wnioski:  Wiarygodność RIDT i DFA u dzieci jest porównywalna, czułość obu testów jest umiarkowana, 
a swoistość bardzo wysoka. Oba testy mogą być używane jako metody skriningowe w diagno-
styce grypy u dzieci z objawami grypopodobnymi.
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       -               -               -               -               -       Diagnosis of influenza by immunoenzymatic assay has led 
to the development of easy-to-use, self-contained diagno-
stic kits that can provide results within 15 minutes after 
specimen collection. The World Health Organization has 
issued recommendations for the use of such kits [33]. In 
contrast to traditional laboratory methods, such as virus 
isolation from cell culture or real-time PCR, RIDTs are 
widely used in a routine clinical setting. However, RIDTs 
may have low to moderate sensitivity and their results sho-
uld be interpreted very carefully by practitioners [9,11,33].
Another rapid detection method is direct immunofluorescen-
ce assay (DFA), which can generate results within 1–4 hours 
but requires specialized and experienced staff and specialized 
equipment. Generally, the sensitivity of DFA is higher than 
that of the rapid antigen test. Sensitivity of DFA is also higher 
among pediatric patients, especially those admitted with high 
fever and spreading high amounts of viruses [3,14,16,19,23].
The aim of our study was to estimate the accuracy of two 
rapid influenza diagnostic methods, RIDT and DFA, com-
pared to real time RT-PCR in children younger than 59 
months with acute symptoms of respiratory tract infection 
consulted in an ambulatory care setting. We chose this age 
group of patients because influenza is an epidemiological, 
clinical and economic problem for these patients, their ca-
regivers and health care services. Depending on age, at-
tack rates of influenza may be 1.5–3 times higher than for 
adults and are estimated to be between 10 and 40% each 
year [28]. Influenza in the pediatric population leads to a si-
gnificant increase in primary care visits, emergency depart-
ment visits and hospitalizations due to complications [28].
According to our current knowledge, our study is the first 
one in Poland exploring this problem.
Material and Methods
A total of 150 patients (70 boys and 80 girls) aged 0-59 
months (mean age 34.3 months, SD 14.3 months) were inc-
luded in the study. All patients came from ambulatory care 
settings and met symptoms of influenza-like illness (ILI) 
according to the CDC definition (fever >38.7°C plus cough 
and/or sore throat in the absence of another known cause 
of illness) lasting less than 4 days (96 hours). Exclusion 
criteria for the study were age older than 59 months, du-
ration of symptoms longer than 96 hours, current antibio-
tic therapy or antiviral therapy.
The observation was performed in two consecutive influ-
enza seasons: 2009/2010 and 2010/2011. Nasopharyngeal 
swabs were taken from all patients by previously trained 
staff using special artificial sticks (ending with viscose). 
The specimens were tested for influenza with both the ra-
pid influenza diagnostic test (RIDT) BD Directigen™ 
EZ Flu A+B® (Becton, Dickinson and Company, Sparks, 
MD) (150 patients) and direct immunofluorescence assay 
IMAGENTM Influenza Virus A and B (Oxoid) (95 pa-
tients), strictly according to the manufacturer’s instruc-
tions. Results of RIDT were available during 15 minutes 
in the office. DIA and real time RT-PCR were performed 
by qualified personnel at the National Influenza Center in 
Warsaw (Poland). Isolation of viral RNA was conducted 
with Maxwell® 16 Viral Total Nucleic Acid Purification 
Kit (Promesa Corp., USA). One-step RT-PCR was con-
ducted with Transcriptor One-step RT-PCR Kit (Roche 
Diagnostics, Switzerland). Real time RT-PCR was conduc-
ted with Invitrogen SuperScriptTM III Platinum® One-Step 
Quantitative RT-PCR System (Invitrogen, USA) using the 
CDC Realtime RTPCR (rRTPCR) Protocol for Detection 
and Characterization of Swine Influenza (version 2009) 
(http://www.who.int/csr/resources/publications/swineflu/
CDCrealtimeRTPCRprotocol_20090428.pdf).
The sensitivity, specificity, positive predictive value, ne-
gative predictive value, positive likelihood ratio, negative 
likelihood ratio of rapid influenza detection test and di-
rect immunofluorescent assay compared to real time re-
verse transcriptase polymerase chain reaction (real time 
RT-PCR) were calculated, by using standard formulae 
(table 1) and the medical statistical calculator available at 
www.medcal3000. 95% confidence intervals were calcula-
ted. The analysis of logistic regression was used to descri-
be the impact of duration of symptoms on the sensitivity 
of RIDT (OR and 95% CI were calculated). The statisti-
cal program CRAN-R was used. The approval of the Local 
Ethical Committee of Warsaw Medical University was ob-
tained for the study (no. KB 165/2011).
results
For RIDT there were obtained 28 true positive, 102 true 
negative, 3 false positive and 17 false negative results. For 
DFA there were obtained 27 true positive, 48 true negati-
ve, 2 false positive and 18 false negative results.
The accuracy of RIDT and DFA compared to real time RT-
PCR is presented in table 2.
The positive and negative predictive values were calculated 
for estimated prevalence of influenza at the level of 20%.
The chance of obtaining a true positive result of RIDT or 
DFA was twice as high when the duration of symptoms 
was shorter than 48 hours and, generally, the chance of ob-
taining a true positive result of RIDT decreased with lon-
ger duration of symptoms (table 3).
Value Calculation formula
Sensitivity No. of true positives/no of true 
positives and false negatives
Specifity No. of true negatives/ no of true 
negatives and false positives
Positive predictive value No. of true positives/ no of 
true positives plus no. of false 
positives
Negative predictive value No. of true negatives/ no of 
true negatives plus no. of false 
negatives
Positive likehood ratio Sensitivity/ 1 minus specifity
Negative likehood ratio 1 minus sensitivity/ specifity
Table 1. Formulae used for calculation of accuracy of RIDT and DFA
Postepy Hig Med Dosw (online), 2012; tom 66: 752-757
754 
       -               -               -               -               -       discussion
Our results indicate a comparable and moderate accura-
cy of both rapid influenza diagnostic methods, RIDT and 
DFA, in the detection of infections caused by A (H1N1)
pdm09 virus in a homogeneous group of children aged 0–59 
months consulted in primary care settings with symptoms 
of influenza-like illness.
Values estimated in our study, describing specificity and 
sensitivity of RIDT BD Directigen EZ Flu A+B®, are lo-
wer than these indicated by the manufacturer and calcula-
ted for a viral culture as a gold standard [4]. This may be 
a result of different sample types taken in our study (pha-
ryngeal and nasal swabs), while the manufacturer tested 
nasopharyngeal swabs or pharyngeal swabs. Our observa-
tion proves that the accuracy of RIDT should be evaluated 
in everyday practice because many factors may influence 
its results, including for example age of patients and the 
subtype of virus circulating in the population.
One of these possible factors influencing the sensitivity of 
RIDT and DFA is the duration of symptoms of ILI. In our 
study we found that the chance of obtaining a true positi-
ve result of RIDT was twice as low when the symptoms 
lasted longer than 48 hours and the logistic regression 
analysis indicated that longer duration of symptoms was 
negatively associated with RIDT performance. Our obse-
rvation is consistent with the results obtained by Hawkes 
et al. [18]. Gordon et al. also observed that the sensitivity 
was significantly lower when the samples for RIDT were 
collected on the day of symptom onset compared to sam-
ples collected one or two days following symptom onset 
(41.7% vs 72.1%) [16]. Time-dependent sensitivity of a 
rapid antigen test in patients with A (H1N1)pdm09 in-
fluenza was also described by Lee et al. [22] – the most 
appropriate time frame for sample collection for the de-
tection of influenza virus in RIDT was 24–96 hours (sen-
sitivity 75–79.9%).
We found that the DB Directigen Ez A+B Flu test perfor-
med moderately well, with an intermediate sensitivity and 
a high specificity in comparison to the CDC real time RT-
PCR assay for influenza A (H1N1)pdm09. Several stu-
dies have been published on the performance of the BD 
Directigen EZ A+B Flu test in detecting influenza A (H1N1)
pdm09, with reported sensitivities ranging from 20.6% to 
70.4% [1,5,6,10,18]. Our sensitivity estimate of 62% falls 
within the estimate of previously reported sensitivities and 
is very similar to the estimate of sensitivity of 70.4% from 
the Blazguez et al. study [5], but higher than reported by 
Karre et al. (48.7%) [20] and Vasoo et al. (46.7%) [32]. 
Possible reasons for the higher sensitivity of RIDT in our 
study may include the fact that we tested young children 
aged less than 59 months. It has been proven that the sen-
sitivity of the RIDT increases with younger age of patients 
and it is believed to be a result of more intensive and lon-
ger lasting replication and shedding (transmission) of in-
fluenza virus in children compared to adults. Hawkes et 
al. found that the sensitivity of RIDT for detection of in-
fluenza A (H1N1)pdm09 virus was higher in a pediatric 
population than in a previously reported mixed adult pa-
tient population [18]. Gao et al. reported that the sensiti-
vity of RIDT was higher among children younger than 2 
years (85.7%) than patients aged 2–39 years (33.3%) [15]. 
A similar observation was reported by Landry et al. for se-
asonal influenza (the sensitivity of BD Directigen EZ Flu 
A+B – 75%) [21].
Another reason for higher sensitivity of RIDT reported in 
our study could be that we used fresh samples for testing 
while some researchers used frozen samples; studies using 
frozen specimens or specimens delayed in testing reported 
worse accuracy of RIDT [17,29].
The BD Directigen EZ Flu A+B® in our study revealed a 
moderate positive predictive value (68.6%), and high ne-
gative predictive value (94.1%). These results would be 
more typical for prevalence of influenza estimated as low 
(<10%) while we conducted the study during the autumn 
and winter season (between 1 November and 31 March) 
when the prevalence of the disease is expected to be hi-
gher, especially as the 2009/2010 season was a pandemic 
season with predominance of type (H1N1)pdm09 influen-
za virus. Moderate positive predictive value of the RIDS 
may be explained by the changing prevalence of influenza 
in different months, even different weeks of the season, as 
described by some authors [18,27].
RIDT [%] DIF [%]
Sensitivity 62.2
95 CI 46.5–76.2%
60
95 CI 51.9–63.2
Specifity 97.1
95 CI 91.8–99.4
96
95 CI 88.7–98.8
Positive predictive 
value
90.3
95 CI 74.3–98
93.1
95 CI 80.5–98
Negative predictive 
value
85.7
95 CI 78.1–91.5
72.7
95 CI 67.2–74.9
Positive likehood 
ratio
21.778
95 CI 6.977–67.979
15
95 CI 4.594–55.566
Negative likehood 
ratio
0.389
95 CI 0.267–0.567
0.417
95 CI 0.372–0.542
Kappa score 0.652
95 CI 0.509–0.794
0,57
95 CI 0.413–0.632
Table 2.   Comparison of the accuracy of rapid influenza detection test 
(RIDT) and direct immunofluorescent assay (DFA)
Duration of symptoms
[hours] OR 95% CI
>48  0.224 0.136–0.368
<48  0.402 0.269–0.603
<24  0.644 0.57–0.727
24–48 0.414 0.325–0.529
48–72 0.267 0.185–0.385
72–96 0.172 0.105–0.280
Table 3. Duration of symptoms as the predictor of true positive RIDT result
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       -               -               -               -               -       Positive and negative likelihood ratios are independent 
values from the prevalence of the diseases and in our stu-
dy we observed a high positive and low negative likeliho-
od ratio (respectively), which is similar to data reported 
by other investigators: Poehling et al. found a positive and 
negative likelihood ratio of respectively 126 and 0.18 [27].
The second rapid method of diagnosis of influenza is a di-
rect immunofluorescent assay. The sensitivity of DFA for 
the pandemic virus A (H1N1)pdm09 ranged from 32.35–
38.7% to 65% [18,22,23]. The sensitivity of DFA in our 
study was and our result is consistent with the results of 
other researchers. Sandora found the sensitivity of DFA in 
detection of influenza A (H1N1)pdm09 infection as high 
as 53%, specificity 99% [30]. Bakerman et al. reported the 
sensitivity of DFA of 65% (specificity 99.6%) [3].
In our study the accuracy of RIDT was comparable with 
the accuracy of DFA, and we conclude that in young chil-
dren aged less than 5 years, consulted with symptoms of 
ILI in primary care settings, the RIDT may be a sound tool 
in the diagnosis of influenza and the method of choice for 
screening for influenza infections and there is no need to 
conduct immunofluorescence assays as they are more time 
consuming, more expensive, and require access to a well-
-equipped laboratory and highly trained laboratory per-
sonnel. RIDT should be especially used in resource-limi-
ted settings where equipment, reagents and laboratory staff 
are not always available.
In our study both methods “missed” one-third of infected 
individuals. Clinicians must be aware of the limitations of 
RIDT and the results should be interpreted cautiously. In 
an epidemic or pandemic season false negative results oc-
cur more often than false positive results. The physician 
should consider sending respiratory specimens of patients 
with negative results received in RIDT for influenza testing 
by RT-PCR or viral culture or DIA, especially when com-
munity influenza activity is high, and particularly when 
the patient is in the risk group of severe course of disease 
and complications [9,11,12,33]. For children at high risk 
with influenza-like illness during high-prevalence periods 
of influenza, empiric initiation of antiviral therapy should 
be considered for patients with negative RIDT results [33].
Both methods – the rapid influenza detection test and di-
rect immunofluorescent assay – allow one to differentiate 
between influenza type A and type B infection, but they do 
not provide information concerning the subtypes of the vi-
rus [2,3]. The gold standard for diagnosis of influenza and 
for evaluation of diagnostic tests is still viral culture, but 
molecular biology methods (PCR and RT-PCR) are also 
considered as gold standard, especially for clinical diagno-
sis [9,11,33]. Potentially, the most important aspect of this 
rapid test is that it can provide timely, accurate and useful 
information for clinicians. The information can be provi-
ded in real time when the diagnostic, isolation and thera-
peutic questions need to be addressed and solved, not ho-
urs later. Laboratory methods based on molecular biology 
should be recommended to all patients with a severe cour-
se of the disease suspected for influenza, even when RIDT 
provided a negative result. Laboratory-based surveillance 
is also needed in order to obtain information on currently 
circulating influenza viruses, and the emergence and pre-
valence of antiviral resistant strains [33].
One advantage of our study is the homogeneous group of 
patients (children younger than 59 months) while most stu-
dies dedicated to evaluation of rapid influenza tests have 
been conducted on adult, mixed adult and pediatric patients 
or among patients aged 0–18 years [2,7,8,24,31].
Another advantage of our study is that it was conducted 
in out-patient settings while most other studies were per-
formed in hospital settings or emergency units [24,30,31].
There are several limitations of our study. The sample size 
for calculation of the accuracy of RIDT and DFA was rela-
tively small, although limited to a very age-related homo-
geneous group of patients. Another limitation is that DFA 
was not conducted for each sample (samples were collec-
ted in the primary care setting, in the evening hours and at 
weekends too; laboratory staff and equipment required for 
DFA testing were not available every time).
conclusions
The rapid influenza detection test BD Directigen EZ Flu 
A+B® is characterized by moderate accuracy which is com-
parable to the direct immunofluorescence assay accura-
cy. RIDT may be used as a screening test in a differential 
diagnosis of influenza caused by type A virus in children 
younger than 59 months consulted in the primary care set-
ting with symptoms of ILI.
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